Lung Cancer clinical trials
230 active trials name this condition (recorded in the registry as “Lung Carcinoma”) . Describe your situation to see which ones you may be eligible for.
Refine by biomarker
By location
- Accelerated Pulmonary Rehabilitation in the Preoperative Period
- Padeliporfin VTP Using Robotic Assisted Bronchoscopy in Peripheral Lung Cancer
- Post-operative Urinary Retention (POUR) Following Thoracic Surgery
- A Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subjects With Oral and Lung Cancers
- Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery
- Avecure Flexible Microwave Ablation Probe For Lung Nodules
- Erector Spinae Block for Thoracic Surgery
- Tobacco Education and Lung Health Study (TEAL)
- Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers of the Central Lung
- Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung
- Image Guided VATS vs. VATS Resection
- Cryodevitalization for the Treatment of Early Stage Lung Cancer, CRYSTAL Trial
- Definitive Radiation for High-Risk Spine Metastases
- Visugromab in Cachexia International Trial
- Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial
- Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer
- Smoking Cessation CM for Veterans With or at Risk for Cancer
- Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast or Lung Cancer
- Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
- Y-NM600 in Patients Receiving Anti-PD-1 or Anti-PD-L1 for Metastatic Cancer
- Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
- Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors
- Brodalumab in the Treatment of Immune-Related Adverse Events
- Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors
- IDOV-Immune for Advanced Solid Tumors
- Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
- Stereotactic Magnetic Resonance Guided Radiation Therapy
- The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
- A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
- A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- Promoting Radon Testing Among Mothers of Young Children
- Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African Americans
- Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
- Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial
- CONNECTing to LungCare
- Healthy Homes Study
- Intrathecal Morphine for Analgesia in Video-assisted and Robotic-assisted Thoracic Surgery
- Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer
- Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
- A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to Increase Lung Cancer Screening Among Black Community Members, RESTORE Trial
- Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Implementation
- CHAMP Lung Cancer Screening Program
- Leveraging the Emergency Department (LEAD) Study
- A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
- Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington State, SACRED LUNGS Trial
- Health Education Approach to Lung Screening
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Lung Carcinoma” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.